Core Insights - The article emphasizes the rapid transition of molecular biology technologies from "basic research breakthroughs" to "precision medicine and biotechnology industry" [1] - Key technologies such as gene editing, high-sensitivity nucleic acid testing, and epigenetic regulation are highlighted as essential tools for understanding disease mechanisms, advancing biological breeding, and enhancing clinical diagnostics [1] Event Details - The series of webinars titled "Frontier Technologies and Translational Applications in Molecular Biology" is organized by Instrument Information Network, focusing on the latest advancements in molecular biology [1] - The event will take place from January 23 to April 17, 2026, featuring various sessions on gene editing and epigenetic regulation [2] Conference Agenda - The first session on January 23 will cover topics such as high-precision mitochondrial DNA base editors and advancements in gene editing research [2] - Notable speakers include researchers from West Lake University and Fudan University, as well as application experts from Bio-Rad Laboratories [2]

Core Viewpoint - The article announces the public listing of the selected units for the 2025 Major Environmental Technology Equipment Innovation Task, which includes various monitoring and analysis equipment related to environmental protection [1][2]. Group 1: Selected Equipment and Companies - The selected equipment includes three types of online automatic monitoring equipment for volatile and semi-volatile organic compounds in water, three high-precision greenhouse gas and stable carbon isotope automated analyzers, and three microscopic Fourier infrared spectrometers [2]. - The companies involved in these innovations include ZETIAN CHUNLAI, XUEDILONG, and others, with specific equipment types and their respective participating and recommending units listed [2][3][4][5][6][7][8][9]. Group 2: Specific Equipment Details - For the online automatic monitoring equipment for volatile and semi-volatile organic compounds, three units are led by Beijing Jingyi Intelligent Technology Co., Chengdu Ailiben Technology Co., and Sinopec Dalian Chemical Research Institute [3]. - The high-precision greenhouse gas and stable carbon isotope automated analyzers have three leading units, including Hebei Ziyue Machinery Equipment Co. and Zhejiang Zheda Mingquan Technology Co. [4]. - The microscopic Fourier infrared spectrometers are led by Beijing Beifen-Ruili Analytical Instrument Group Co. and Hangzhou Zetian Chunlai Technology Co. [5]. - The underground water typical organic pollutant online monitoring systems have two leading units, including Zhejiang Weilan Environmental Technology Co. and Sinopec Dalian [6]. - The high-precision monitoring equipment for particulate matter using light scattering has five leading units, including Beijing Leidi Long Technology Co. and Anhui Kexin Zhongguang Technology Co. [7]. - The monitoring-type noise map complete equipment has four leading units, including Beijing Science and Technology Research Institute and Hangzhou Aihua Instrument Co. [8]. - The high-sensitivity portable gas chromatography-mass spectrometry (GCMS) for ozone-depleting substances has four leading units, including Beijing Xuedilong Technology Co. and Sichuan Shengshi Technology Co. [9].

详细采购清单： 新疆医科大学2 0 2 5年8月~ 2 0 2 6年1 2月 摘要 ： 近日，新疆医科大学发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理，统 计出2项仪器设备采购意向，预算总额达1.35亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 近日，新疆医科大学发布1项2 0 2 6年仪器设备采购意向，预算总额达3 6 4 1万元，涉及医药科技 创新平台设备和2 0 2 6年度科研经费采购科研教学仪器，预计采购时间为2 0 2 6年1 2月。 项目 采购 备更新项目为学校购置教学实训与科研设备，包含设备的 运输、安装与调试。达到预期目标。 采购 项目 需求概况 预算 万元 采 购 时 间 2026 年度 科研 经费 采购 科研 采购标的名称：新疆医科大学2026年度科研经费采购科研 教学仪器项目，主要为科研教学专用、通用设备，项目按 照科研经费申报流程分期分批执行，项目整体完成时间为 2026年12月。采购标的数量：新疆医科大学2026年度科 研经费采购科研教学仪器项目，主要为科研教学专用、通 用设备，项目按 ...

Group 1 - The core viewpoint of the article is that Duoning Biotechnology Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, indicating its intention to go public [1] - Duoning Biotechnology was established in 2005 and is a one-stop provider of bioprocessing solutions, focusing on comprehensive solutions for biopharmaceutical products from research and development to commercial production, including reagents, consumables, instruments, and services [1] - The company previously submitted a prospectus to the Hong Kong Stock Exchange on September 26, 2022, aiming to list on the main board in Hong Kong [1]

Core Viewpoint - The article discusses the announcement of the application process for national project awards related to "Frontier Technology Research in Future Industries" and "High-end Scientific Instruments and Reagents Software Development" in the Minhang District, emphasizing support for innovative research and development in key technological areas [1][2]. Group 1: Policy Content - The policy supports research in future industries such as quantum technology, aerospace, synthetic biology, and new energy storage, encouraging interdisciplinary basic research and disruptive technology breakthroughs. Projects receiving national support will be awarded up to 20% of total project investment, with a maximum of 3 million yuan [1][3]. - There is a focus on promoting the independent research and market application of high-end scientific instruments, research reagents, and basic software, with similar financial support conditions as mentioned above [2][3]. Group 2: Support Standards and Conditions - Projects that receive national project approval in the fields of quantum technology, aerospace, synthetic biology, and new energy storage, as well as high-end scientific instruments, research reagents, and basic software, will be eligible for financial rewards of up to 20% of national funding, capped at 3 million yuan [3]. - Eligible applicants must be registered and taxed within the "Big Zero Bay" area, possess independent legal status, and have projects that have received national funding in the specified technological areas [4]. Group 3: Application Process - The application process is conducted online, eliminating the need for paper submissions. Applicants must log in to the Minhang Enterprise Corridor using the "Legal Person One Certificate" and follow the prompts to fill out the application form [6]. - Required attachments include scanned copies of project approval notifications, task books, and funding certificates corresponding to each level of the project [6]. Group 4: Application Notes - Applicants are responsible for the authenticity, completeness, validity, and legality of the materials submitted and are subject to supervision and inspection by relevant authorities [7].

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 今日，海能未来发布业绩预告公告： 海能未来技术集团股份有限公司2025年年度业绩预告公告 特别提示：本公告所载2025年年度主要财务数据为初步核算数据，未经会计师事务所审计，具体数据以公司2025年年度报告中披露的数 据为准，提请投 资者注意投资风险。 一、本期业绩预告情况 (一)业绩预告期间 2025 年1月1日至2025年12月31日。 (二)业绩预告情况 √年度实现盈利，且净利润与上年同期相比上升50%以上 213.65%～236.61%报告期内，预计归属于上市公司股东的净利润同比大幅增长，主要原因系： 1、报告期内，行业市场需求整体回暖，高端仪器国产制造趋势显著、设备更新政策逐步落地，公司在新材料、新能源、制药等领域增长 较快。报告期内， 预计实现营业收入约3.62亿元，同比增长约16.77%，各系列产品收入均实现增长。 2、公司基于对行业长期发展的信心，近年来在产品研发、市场拓展、品牌提升等方面保持持续投入，推出了有机元素分析仪、液相色谱 仪等高端仪器产品，在高端仪器智能化、数字化方 ...

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 近 日 ， 石 河 子 大 学 发 布 3 1 项 仪 器 设 备 采 购 意 向 ， 预 算 总 额 达 1 . 4 0 亿 元 ， 涉 及 恒 温 培 养 箱、生物安全柜、落地离心机、酶标仪、高效液相、粒径电位仪、超低温- 8 0 ℃ 冰箱、冷冻干 燥机、小型高速冷冻离心机、超声细胞破碎仪、灭菌锅、超微量分光光度计等，预计采购时间 为2 0 2 5 年 3 月 ~2 0 2 6年3月 。 详细采购清单： | 超 | 滤 | 膜 | 检 | 测 | 器 | 、 | 高 | 压 | 细 | 胞 | 破 | 碎 | 仪 | 、 | 自 | 分 | 离 | 设 | 动 | 电 | 位 | 滴 | 定 | 仪 | 、 | 高 | 效 | 逆 | 流 | 色 | 谱 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- ...

摘要 ： 本文梳理了全国各省市国家实验室和省实验室建设名单，并收集了高校的参与情况，一睹科技力 量建设中的高校担当。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 1月12日，河北省科技厅发布消息，由河北清华发展研究院牵头，联合 清华大学、河北医科大 学、河北中医药大学 等共建的 燕赵生物医药实验室 筹建工作获省科技厅批复，标志着该实验 室进入实质性建设阶段。据悉，这是河北省启动建设的第五个"燕赵实验室"。 目前我国实验室体系正在加快调整。国家实验室正在新建，全国重点实验室正在重组，各地方 正在积极建设省实验室。省实验室被看作国家实验室的预备队、潜力股。 中央批准成立的新型 科研机构鹏城国家实验室 曾作为广东省首批4家省实验室 之一启动建设；首批浙江省实验室 西湖实验室 明确表示，将以国家级生命健康创新平台为建设目标……本文梳理了 全 国 各 省 市 国家实验室和省实验室建设名单，并收集了高校的参与情况 ， 一睹科技力量建设中的高校担 当。 国家实验室，战略科技重器 党的十八大以来，习近平总书记多次提及国家实验室的布局和建设，从不同层面 ...

Group 1 - The article discusses the establishment of Chengguang Optical Technology (Sichuan) Co., Ltd., with a registered capital of 1.337 billion yuan [1] - The company is involved in the manufacturing of optical instruments, electronic components, and the research and development of electronic materials [1] - Shareholding information indicates that the company is jointly owned by Sichuan Tianfu Rongguang Technology Co., Ltd. and the Chinese Academy of Sciences' Institute of Optoelectronic Technology [1]

Core Insights - Organoid technology is a revolutionary model in life sciences, showing great potential in simulating human organ development, disease mechanism research, and drug development, but faces significant bottlenecks in scaling and standardization [1] - Current organoid research needs to move beyond traditional morphological observations to deeper functional analyses, particularly in assessing cellular energy metabolism, which is crucial for evaluating organoid viability, drug toxicity, and metabolic disease phenotypes [1] - The reliance on manual operations and animal-derived matrix gels in organoid culture leads to significant sample variability and high costs, hindering high-throughput drug screening applications [1] Group 1 - A single technical pathway is insufficient to address systemic issues in organoid research; a cross-platform, multidimensional technical collaboration is necessary to create an integrated solution from model establishment to standardized culture and deep functional characterization [2] - Agilent, in collaboration with Instrument Information Network, will host a webinar on January 21, 2026, titled "Multidimensional Technological Innovation and New Paradigms in Organoid Research," inviting leading scholars and technical experts to discuss pathways for standardized organoid research [2] Group 2 - The agenda for the webinar includes presentations from distinguished guests, such as: - "Construction of Functional Organs Based on Organoid Assembly and Precision Medicine Research" by Dr. Pang Yuan from Tsinghua University [6] - "Instantaneous Dynamics of Organoid Metabolism: Standardized Application of Seahorse XF in 3D Models" by Wei Yufeng from Agilent Technologies (China) [7] - "Multi-modal Automation Platform Compatible with Phenotype and Viability Analysis to Assist in Standardized Organoid Model Establishment" by Yang Jingzhe from Agilent Technologies (China) [7] - "Construction and Application of Engineered Multi-organ Chips: From Absorption Metabolism to Tumor Immune Regulation" by Liu Dongdong from the Chinese Academy of Sciences [7]